RFID Traceability for Healthcare
  • FR
  • EN
  • Access
  • Careers
  • Contact us

C-LOG® Chemotherapy

Innovative new RFID solution for tracking the chemotherapy injectables chain and keeping it safe and secure.

 

 

The medicine circuit in hospital can be lengthy and involves many stages and actors.  Even more involved is the chemotherapy process due to protocol complexity, the delicate manufacturing of preparations, their toxicity and stability, but also due to the fragile conditions of patients.

There are many constraints linked to this circuit: organizational, temporal, material and also economic.

C-log® ensures identification and traceability in real time for each preparation, each stage of the circuit, each participant, from the preparation unit all the way to administering in care service.

  1. SIGNIFICANT REDUCTION OF MANUAL HANDLING

RFID provides automatic traceability through contactless read/write of critical information.

  1. INFORMATION RETAINED ON THE RFID TAG

Such as the patient identifier, the product, the dosage, the administering method, the due date and time. Available at any time depending on the appropriate authorization level of the user.

  1. INDISPENSABLE SUPPORT TO VIGILANCE

Through unfailing cross-control at the patient bedside for the right treatment to the right patient : right patient, right drug, right dose, right route, right time.

  1. COST CONTROL

By minimizing the risks of product loss, out-of-date usage, and incorrect administration, leading to direct and/or indirect cost benefits for the hospital.

 

One of the advantages of this technology is the ability to trace preparations between the different hospital sites of Institut Curie. This was of great interest to Curie who collaborated with Biolog-id in the development of this project and in the running of the pilot study.

This project, which involves about fifteen people, has defined the specifications of the C-LOG system in agreement with the medical staff (pharmacists, nurses, porters...), and then will run the pilot study in parallel with the existing system.

The aim is to validate the pilot and implement the system in the Curie Institute, then to offer it to other establishments who wish to acquire it, in France and in other countries.

press releases Chemotherapy

04/06/2013 - Curie-Cancer and Biolog-id sign partnership agreement to develop a traceability system for cancer chemotherapy preparations
Within the partnership, Curie-Cancer and Biolog-id will develop a pilot system of RFID tags suitable for use in tracking cancer chemotherapy preparations. - See more